ResMed puts $225m on the table for Propeller Health

ResMed (NYSE:RMD) said today that it inked a deal to acquire Propeller Health and its digital medicine platform for $225 million in cash.

Propeller Health, which sells small sensors that attach to inhalers and track medication use, will operate as a standalone business under ResMed’s respiratory care portfolio.

Get the full story at our sister site, Drug Delivery Business News.

The post ResMed puts $225m on the table for Propeller Health appeared first on MassDevice.

from MassDevice https://ift.tt/2Q9pC0u